About Aptuit
Aptuit is a Healthcare company based in Greenwich (United States) founded in 2004, and was acquired by Evotec in July 2017. Contract research and development services for small molecules are offered. Aptuit has raised $14.23 million across 4 funding rounds from investors including Evotec, Welsh, Carson, Anderson & Stowe and Temasek. Aptuit has completed 2 acquisitions, including Exquiron and Kuecept. Aptuit offers products and services including Pipeline Co-Creation, CRO Services, CDMO Services, and PanOmics Platform. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its competitors include Asymchem, Continuus Pharma and Pharmaceutics International; 1 of its 3 listed competitors has raised funding.
Company details
Aptuit was founded in 2004 in Greenwich, United States, within the pharmaceutical sector. Contract research and development services for small molecules are provided, encompassing drug discovery, preclinical testing, API development and manufacturing, and finished product formulations for inhalation, solid, and oral dosages. A custom Indigo service is also offered to enhance drug bioavailability. Operations focus on supporting pharmaceutical innovation through these specialized capabilities.
- Headquarters Greenwich, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website aptuit.com
- Social LinkedIn X
- Acquired by Evotec (Jul 2017)
Products & Services of Aptuit
Aptuit offers a comprehensive portfolio of products and services, including Pipeline Co-Creation, CRO Services, CDMO Services, and PanOmics Platform.
Service for co-creating drug pipelines with partners
Outsourced R&D for therapeutic development and testing
Contract development and manufacturing of biotherapeutics
AI-driven tool for disease understanding and drug discovery
Funding Insights of Aptuit
Aptuit has successfully raised a total of $14.23M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $271.63 thousand completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.23M
- Total Rounds 4
- Last Round Grant — $271,632
- First Round $13.76M
(Apr 2006)
- Investors Count 3
All 4 funding rounds of Aptuit with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2017 | $271,632 | Grant | – | – | |
| Jan 2015 | $311,960 | Grant | – | – | |
| Jun 2010 | $467,000 | Series B | – | – | – |
| Apr 2006 | $13.76M | Series B | – | Temasek |
4 investors in total: 4 institutional.
Investors in Aptuit
Aptuit has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Evotec, Welsh, Carson, Anderson & Stowe and Temasek.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
An investment platform is provided for diverse sectors and geographies. | 1974 | temasek.com.sg | Singapore, Singapore | |
Healthcare and technology sectors are targeted for private equity investments. | 1979 | wcas.com | New York, United States | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Drug discovery and development services are provided to biopharma sector. | 1993 | evotec.com | Hamburg, Germany |
Investor details for Aptuit
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aptuit
Aptuit has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Exquiron and Kuecept.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Preclinical formulation, chemistry, manufacturing, and control services are provided. | kuecept.com | Abingdon, United Kingdom | 2007 | May 2016 | •••• | |
Early-stage drug discovery services are provided as a CRO. | exquiron.com | Reinach, Switzerland | 2012 | Apr 2016 | •••• |
Complete acquisition details for Aptuit
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Aptuit
6 dated milestones of Aptuit across 13 years, from founding to its latest funding, stage changes and deals.
Competitors of Aptuit
Aptuit has 3 listed competitors in our database, 1 of them funded. They include Asymchem, Continuus Pharma and Pharmaceutics International.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| asymchem.com | 1995 | Morrisville, United States | 48 | APIs and peptides are developed and manufactured by Asymchem. | ||
| continuuspharma.com | 2012 | Woburn, United States | $7.73M | 47 | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | |
| pharm-int.com | 1994 | Hunt Valley, United States | 248 | Pharmaceutical dosage forms are manufactured by this CDMO. |
Detailed competitors of Aptuit
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Aptuit
Websites that share an audience with Aptuit (aptuit.com).
Websites whose visitors overlap most with Aptuit. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| criver.com | 100% | 224.6K | #186,811 | View details | |
| alnylam.com | 77% | 77.8K | #414,009 | View details | |
creative-biolabs.com | creative-biolabs.com | 67% | #348,062 | – | |
| quintiles.com | 43% | #377,823 | View details | ||
| astrazeneca.com | 41% | 1.3M | #48,983 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Aptuit (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aptuit
Complete news archive for Aptuit
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aptuit
Aptuit was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Aptuit is headquartered in Greenwich, United States. It is registered at Greenwich, Connecticut, United States.
Aptuit is a funded company, having raised a total of $14.23M across 4 funding rounds to date. The company's 1st funding round was a Series B of $13.76M, raised on Apr 2006.
Aptuit was founded in 2004 in Greenwich, United States, within the pharmaceutical sector. Contract research and development services for small molecules are provided, encompassing drug discovery, preclinical testing, API development and manufacturing, and finished product formulations for inhalation, solid, and oral dosages. A custom Indigo service is also offered to enhance drug bioavailability. Operations focus on supporting pharmaceutical innovation through these specialized capabilities.
Aptuit's top competitors include Pharmaceutics International, Asymchem and Continuus Pharma.
Aptuit offers Pipeline Co-Creation, CRO Services, CDMO Services, and PanOmics Platform.
Aptuit has 4 investors. Key investors include Evotec, Welsh, Carson, Anderson & Stowe, Temasek, and European Union.
Yes. Aptuit was acquired by Evotec in July 2017.